Targeting SMARCA4 mutations in lung cancer

Which Lung Cancer Mutations Have Approved Targeted Therapies?Подробнее

Molecular Tumor Board - SMARCA4 mutation in Lung CancerПодробнее

What targeted therapies are used for people with the EGFR mutation?Подробнее

Understanding Mutations and Targeted Therapy in Lung CancerПодробнее

Treating KRAS G12C MutationsПодробнее

Understanding mutations in lung cancerПодробнее

Target mutations in lung cancerПодробнее

EGFR-Mutant Lung Cancer & Treatment Options | 2023 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее

Lung Cancer Mutations and Treatment AdvancesПодробнее

What is an EGFR mutation for lung cancer?Подробнее

SMARCA4Подробнее

Cytomorphologic and Immunophenotypical Analysis of SMARCA4 (BRG1)-Deficient Non-Small Cell....Подробнее

Lung Cancer Targeted Gene Panel with Rearrangement [A Test in Focus]Подробнее

Extreme Rare Mutations in Lung Cancer (ROS1, TRK, HER2): Treatment opportunitiesПодробнее

August 27, 2022, Revolution Cancer International Molecular Tumor Board -GSK, SMARCA4, MTAP, NSCLCПодробнее

Metastatic Non-Small Cell Lung Cancer (NSCLC) Algorithm w/ Targetable Mutations- Dr. Jarushka NaidooПодробнее

Diagnostic testing for genetic mutations in lung cancerПодробнее

The identification of actionable mutations in lung cancer via ctDNAПодробнее

Osimertinib in Advanced Non–Small-Cell Lung CancerПодробнее